Dermatology company with two FDA approved products marketed by Galderma in the US
Read More
Advanced pipeline of products for the treatment of rare skin diseases
Read More
Previous
Next

TWYNEO® is now available in the U.S. for the treatment of Acne Vulgaris

Learn More

EPSOLAY® is now available in the U.S. for the treatment of Inflammatory Lesions of Rosacea

Learn More

Our Product Pipeline

Sol-Gel is developing a diverse pipeline of innovative topical skin medications

View Our Pipeline